dr perlmutter parkinson's glutathione Randomized, doubleâ•'blind, pilot evaluation of intravenous in Parkinson's disease
$25.03
Description
We have added it to a list of your favorite stories
Abstract An increase in the number of elderly people suffering from the symptoms of Parkinsons disease is leading to an expansion in the market size of 3,4-dihydroxyphenyl-l-alanine (l-DOPA), which is the most commonly used drug for the treatment of this disease
Important Notice: Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease
Treatment may include CBT-I, sleep schedule support, mental health care, medication review, sleep apnea screening, circadian rhythm interventions, or other individualized options
Personalized treatment: Dr
